Five-Year Cervical (Pre)Cancer Risk of Women Screened by HPV and Cytology Testing

Cancer Prevention Research
M H UijterwaalChris J L M Meijer

Abstract

Primary human papillomavirus (HPV)-based cervical screening will be introduced in the Netherlands in 2016. We assessed the 5-year cervical (pre)cancer risk of women with different combinations of HPV and cytology test results. Special attention was paid to risks for cervical intraepithelial neoplasia grade 3 and 2 or more (CIN3+/2+) of HPV-positive women with a negative triage test, because this determines the safety of a 5-year screening interval for HPV-positive, triage test-negative women. In addition, age-related effects were studied. A total of 25,553 women were screened by HPV testing and cytology in a screening setting. Women were managed on the presence of HPV and/or abnormal cytology. Five-year cumulative incidences for CIN3+/2+ were calculated. Five-year CIN3+(2+) risk was 10.0% (17.7%) among HPV-positive women. When stratified by cytology, the CIN3+(CIN2+) risk was 7.9% (12.9%) for women with normal cytology and 22.2% (45.3%) for women with equivocal or mildly abnormal (i.e., BMD) cytology. For HPV-negative women, the 5-year CIN3+(2+) risk was 0.09% (0.21%). Additional triage of HPV-positive women with normal cytology by repeat cytology at 12 months showed a 5-year CIN3+(2+) risk of 4.1% (7.0%). HPV-non 16/18-positiv...Continue Reading

References

Jan 13, 2000·JAMA : the Journal of the American Medical Association·T C WrightA Lorincz
May 29, 2000·BJOG : an International Journal of Obstetrics and Gynaecology·E H HopmanT J Helmerhorst
Mar 7, 2002·Journal of Clinical Microbiology·Adriaan J C van den BrulePeter J F Snijders
Apr 23, 2002·JAMA : the Journal of the American Medical Association·Diane SolomonUNKNOWN Bethesda 2001 Workshop
Apr 1, 2004·International Journal of Cancer. Journal International Du Cancer·Nicole W J BulkmansChris J L M Meijer
Jan 1, 2008·Obstetrics and Gynecology·Marc ArbynJohan Bulten
Feb 2, 2008·International Journal of Cancer. Journal International Du Cancer·Jack CuzickWilliam P Soutter
Oct 15, 2008·BMJ : British Medical Journal·Joakim DillnerUNKNOWN Joint European Cohort Study
Oct 29, 2009·JAMA : the Journal of the American Medical Association·Albertus G SiebersMarc Arbyn
Nov 12, 2009·Journal of the National Cancer Institute·Maarit LeinonenAhti Anttila
Jan 22, 2010·The Lancet Oncology·Guglielmo RoncoUNKNOWN New Technologies for Cervical Cancer screening (NTCC) Working Group
Mar 15, 2011·International Journal of Cancer. Journal International Du Cancer·Dorien C RijkaartChris J L M Meijer
Apr 13, 2011·International Journal of Cancer. Journal International Du Cancer·Murat GökChris J L M Meijer
Sep 16, 2011·American Journal of Clinical Pathology·Thomas C WrightUNKNOWN ATHENA (Addressing THE Need for Advanced HPV Diagnostics) Study Group
Aug 2, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philip E CastleSholom Wacholder
Dec 5, 2012·Vaccine·Jack CuzickAnne Szarewski
Jun 5, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Maaike G DijkstraJohannes Berkhof

❮ Previous
Next ❯

Citations

Dec 9, 2015·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Mario PoljakEda Vrtačnik Bokal
Jul 4, 2017·International Journal of Cancer. Journal International Du Cancer·Nienke J VeldhuijzenJohannes Berkhof
Oct 13, 2017·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Jan N Bouwes BavinckUNKNOWN EPI-HPV-UV-CA group
Mar 10, 2018·Psycho-oncology·Hersha PatelSusan M Sherman
Mar 19, 2016·International Journal of Cancer. Journal International Du Cancer·Renée M F EbischWillem J G Melchers
Jun 12, 2019·Gynecologic Oncology·Stèfanie DickDaniëlle A M Heideman
Dec 15, 2020·The Journal of Obstetrics and Gynaecology Research·Serdar AydınDilek Sema Arıcı

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Kathleen McIntyre-SeltmanALTS Group
Current Obstetrics and Gynecology Reports
Patricia Luhn, Nicolas Wentzensen
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Sophia S WangDiane Solomon
© 2021 Meta ULC. All rights reserved